Bioquark, a U.S. biotech company announced they’ve received authorization to begin conducting experimental human testings.
Company spokespersons revealed last year researchers believed brain death was reversible. In other words, that people could be brought back from the dead.
And now, CEO Ira Pastor has revealed they will soon be testing an unprecedented stem cell method on patients in an unidentified country in Latin America, confirming the details in the next few months.
To be declared officially dead in the majority of countries, you have to experience complete and irreversible loss of brain function, or ‘brain death’.
According to Pastor, Bioquark has developed a series of injections that can reboot the brain – and they plan to try it out on humans this year.
Bioquark originally wanted to conduct initial testing in India however their request was denied by the Indian Council of Medical Research.
Here is an overview of the Bioquark study taking place this summer in an alternative Latin American country.
The first stage, named ‘First In Human Neuro-Regeneration & Neuro-Reanimation’ was slated to be a non-randomized, single group ‘proof of concept’ study.
The team said they planned to examine individuals aged 15-65 declared brain dead from a traumatic brain injury using MRI scans, in order to look for possible signs of brain death reversal.
Specifically, they planned to break it down into three stages.
First, they would harvest stem cells from the patient’s own blood, and inject this back into their body.Next, the patient would receive a dose of peptides injected into their spinal cord.
Finally, they would undergo a 15-day course of nerve stimulation involving lasers and median nerve stimulation to try and bring about the reversal of brain death, whilst monitoring the patients using MRI scans.
Bioquark critics however are criticizing the biotech giant for violating ethical consent standards and bypassing preliminary animal testings.
The idea of consent in this context is complicated, since the patients are all technically dead.
They have no plans to test on animals first.
—
The Bioquark trials are part of a broader project called ReAnima. Pastor is on the advisory board for ReAnima.
According to the website, the project is ‘exploring the potential of cutting edge biomedical technology for human neuro-regeneration and neuro-reanimation.’
Speaking to MailOnline last year, Pastor said: ‘The mission of the ReAnima Project is to focus on clinical research in the state of brain death, or irreversible coma, in subjects who have recently met the Uniform Determination of Death Act criteria, but who are still on cardio-pulmonary or trophic support – a classification in many countries around the world known as a “living cadaver”.’
Bioquark may very-well be developing a valuable treatment but how trustworthy is a company conducting experimental medical testings on corpses and brain dead people in an undisclosed 3rd world Latin American country.
Source: Dailymail
Cant wait !!!!!
Frankensteen!!!